Novo Nordisk shares pop on early-stage weight loss drug trial results

• 

  Novo Nordisk Shares Surge on New Obesity Drug Results

  Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.
  
  The Wall Street Journal - 3h

• Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.

  Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.
  
  MarketWatch - 6h
• 

  Weight-loss drugs may boost health in many ways, say researchers

  New weight-loss drugs have broad health benefits but also come with risks, researchers warn.
  
  BBC News - 4d
• 

  Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations

  The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.
  
  NBC News - Jan. 17
• 

  Medicare to Negotiate Lower Prices for Weight-Loss Drugs

  The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
  
  The New York Times - Jan. 17
• 

  Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

  Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.
  
  NBC News - Jan. 9
• 

  Smith dumps Diageo stake over impact of weight-loss drugs on alcohol demand

  Veteran stockpicker sells shares in spirits brand because drinks sector is being ‘impacted negatively’
  
  Financial Times - Jan. 9

• Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact

  At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...
  
  MarketWatch - Jan. 8
• 

  Pharma giant seeks to join lawsuit against FDA over weight loss drugs

  Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the "entitlement" some ...
  
  The Hill - Jan. 2

More from CNBC

• Target rolls back DEI initiatives, the latest big company to retreat

  Target joins Walmart, Meta, McDonald's and a wave of other major companies pulling back on DEI programs.
  
  CNBC - 7m

• Trump recommends ending FEMA ahead of California fire site visit

  President Donald Trump will visit California to see the damage caused by wildfires around Los Angeles. FEMA has been involved in response efforts there.
  
  CNBC - 19m

• Zuckerberg sets Meta's AI targets for the year, expects to spend $60 billion on growth

  Meta CEO Mark Zuckerberg announced the company plans to invest around $60 billion to $65 billion in capital expenditures this year
  
  CNBC - 3h

• LNG pure-play Venture Global opens below its $25 per share IPO price

  "The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sabel told CNBC in an interview Friday.
  
  CNBC - 1h

• Meta to begin testing ads on Threads, its micro-blogging app

  Meta will begin testing ads on its Threads microblogging service with a few companies in the U.S. and Japan, the company said in a blog post Friday.
  
  CNBC - 50m

More in Business

• Target rolls back DEI initiatives, the latest big company to retreat

  Target joins Walmart, Meta, McDonald's and a wave of other major companies pulling back on DEI programs.
  
  CNBC - 7m

• Trump recommends ending FEMA ahead of California fire site visit

  President Donald Trump will visit California to see the damage caused by wildfires around Los Angeles. FEMA has been involved in response efforts there.
  
  CNBC - 19m
• 

  Disaster Losses Rose in U.S. in 2024 While Easing Globally

  Damage from two hurricanes and a series of punishing wildfires left a price tag of $218 billion in economic costs last year, an 85 percent jump from 2023.
  
  Inc. - 27m
• 

  EV Truck Maker Nikola Weighs a Sale as Cash Crunch Hits Hard

  The fuel-cell electric truck maker continues to struggle as its cash reserves dwindle.
  
  Inc. - 36m

• Trump’s Crypto Working Group to Draft New Regulations and Explore National Stockpile

  The key takeaway from the president’s directive is that crypto companies should not lose access to banking services, which regularotors say has not occurred.
  
  Inc. - 43m